Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC 332488

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
 
Is this relevant?
Review
1992
Review
1992
The racematic compound a/β-1,2,4-triglycidylurazol (TGU; NSC 332488) a triepoxide with alkylating properties, has a broad… Expand
Is this relevant?
1986
1986
Fourteen patients with metastatic renal adenocarcinoma without prior chemotherapy were treated with 1,2,4-triglycidylurazol (TGU… Expand
Is this relevant?
1986
1986
Twenty-six patients with advanced malignancies received TGU given as an intravenous (i.v.) bolus in physiological saline at 3… Expand
Is this relevant?
1985
1985
1,2,4-Triglycidylurazol, a new triepoxide derivative, was chosen for phase I trial because of its favorable water solubility… Expand
Is this relevant?
1984
1984
Triglycidyl-urazol (TGU) was a rational drug development from the original triepoxide triglycidyl-triazinetrione (TGT). It was… Expand
Is this relevant?